FindTrial
Sign In

Evaluation of Metformin effect on left ventricular function and on energetic metabolism, in patients affected by heart failure and glucidic intolerance. - ND

Evaluation of Metformin effect on left ventricular function and on energetic metabolism, in patients affected by heart failure and glucidic intolerance. - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-010292-24-IT
Enrollment
Unknown
Registered
2009-03-10
Start date
2009-03-26
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients affected by heart failure and glucidic intolerance. MedDRA version: 9.1 Level: LLT Classification code 10008908 Term: Chronic heart failure

Interventions

Trade Name: METFORMINA TEVA Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Metformin Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 500-

Sponsors

OSPEDALE S. RAFFAELE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -patients aged between 18 and 90 years; -FE105 mg/dl). Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: patologies that may creae problems during the study (diabetes mellitus, cancer etc.); -partecipation in another clinical study;etc...

Design outcomes

Primary

MeasureTime frame
Main Objective: to evaluate the functional and metabolic effects of metformine in patients affected by heart failure and glucidic intolerance.;Secondary Objective: to evaluate the functional and metabolic effects of metformine in patients affected by heart failure and glucidic intolerance.;Primary end point(s): evaluation of the changes in cardiac function after supply of metformin to conventional therapy for heart failure.—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026